View by Specialty

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

Vascular Medicine News

SPONSORED CONTENT
Save
SPONSORED CONTENT
October 14, 2024
1 min read
Save

PAH, right ventricular hypertrophy prevalent in patients with ILD

PAH, right ventricular hypertrophy prevalent in patients with ILD

BOSTON — Among patients with interstitial lung disease, 30% had pulmonary arterial hypertension and 20% had right ventricular hypertrophy, according to data presented at the CHEST Annual Meeting.

SPONSORED CONTENT
October 10, 2024
8 min watch
Save

VIDEO: ‘Clear lack of data’ on digital CV health tools for women concerning

VIDEO: ‘Clear lack of data’ on digital CV health tools for women concerning

In this Healio video exclusive, Sana M. Al-Khatib, MD, professor of medicine at Duke University School of Medicine, discusses barriers to developing cardiovascular digital health solutions for women.

Trending

AdobeStock_Carrots_1200x630
November 18, 2024
1 min read
Save

CDC: 1 dead in multistate outbreak of E. coli linked to organic carrots

SPONSORED CONTENT
October 09, 2024
2 min read
Save

Hypertension common, predicted by older age, diabetes in early rheumatoid arthritis

Hypertension common, predicted by older age, diabetes in early rheumatoid arthritis

Hypertension is common in patients with early rheumatoid arthritis, and most frequently develops in older patients and those with traditional cardiovascular risk factors, according to data published in Rheumatology Advances in Practice.

SPONSORED CONTENT
October 09, 2024
4 min read
Save

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

COVID-19 a CV risk equivalent to prior heart disease; type O blood may be protective

Prior SARS-CoV-2 infection, especially for those requiring hospitalization, was associated with increased risk for heart attack and stroke for up to 3 years, even among people with no history of heart disease, researchers reported.

SPONSORED CONTENT
October 08, 2024
1 min read
Save

FDA grants breakthrough device designation to AI-powered aortic stenosis screening tool

FDA grants breakthrough device designation to AI-powered aortic stenosis screening tool

AccurKardia announced its AI-powered, ECG-based aortic valve stenosis screening software has been granted breakthrough device designation by the FDA.

SPONSORED CONTENT
October 07, 2024
2 min read
Save

Noninvasive, wearable device feasible for determining stroke risk

Noninvasive, wearable device feasible for determining stroke risk

Noninvasive speckle contrast optical spectroscopy may be a feasible method for determining whether individuals are at high or low risk for stroke, according to a study published in Biomedical Optics Express.

SPONSORED CONTENT
October 07, 2024
2 min read
Save

Serious cardiovascular events rare after CAR T-cell therapy

Serious cardiovascular events rare after CAR T-cell therapy

A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.

SPONSORED CONTENT
October 03, 2024
1 min read
Save

Study: No clear association between pet ownership and brain, heart health

Study: No clear association between pet ownership and brain, heart health

ORLANDO, Fla. — An analysis of a large cohort of individuals enrolled in a continuous, multinational survey found no clear associations between brain and heart health and pet ownership, according to a poster.

SPONSORED CONTENT
October 02, 2024
3 min read
Save

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

AHA announces late-breaking lineup to be presented at 2024 Scientific Sessions

The American Heart Association Scientific Sessions will be held in-person only in Chicago from Nov. 16 to 18 and will feature eight late-breaking science sessions during the 3-day meeting.

SPONSORED CONTENT
October 02, 2024
4 min read
Save

Q&A: Asporin linked to ‘more favorable disease profile’ in patients with PAH

Q&A: Asporin linked to ‘more favorable disease profile’ in patients with PAH

Asporin has been discovered as a potential new target that may be used when developing therapeutic interventions for pulmonary arterial hypertension, according to a University of California, Los Angeles (UCLA) press release.

View more
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails
Healio Minute Subscribe to Healio Minute emails You're now subscribed to Healio Minute Emails